HI
CRBP icon

Harbour Investments’s Corbus Pharmaceuticals CRBP Stock Holding History

Harbour Investments’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122 Hold
13
– – ﹤0.01% 4595
2026
Q1 		$122 Buy
+13
New +$109 ﹤0.01% 4489
2021
Q4 		– Sell
-80
Closed -$2K – 2833
2021
Q3 		$2K Hold
80
– – ﹤0.01% 3281
2021
Q2 		$4K Buy
80
+33
+70% +$1.83K ﹤0.01% 3128
2021
Q1 		$3K Buy
+47
New +$3.09K ﹤0.01% 3073

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Harbour Investments's CRBP Position: Q2 2026 in Review

Harbour Investments held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 13 shares worth $122. The position accounts for ﹤0.01% of the portfolio, ranked #4595.

Harbour Investments first reported a position in CRBP in Q1 2021 and has held it in 5 quarters since. The position peaked at $4K in Q2 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Harbour Investments held 13 shares of Corbus Pharmaceuticals worth $122 as of Q2 2026.
  • Harbour Investments left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4595 holding.
  • Harbour Investments first reported a position in Corbus Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
  • Harbour Investments's Corbus Pharmaceuticals position peaked at $4K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.